Severe Community-Acquired Pneumonia with Disseminated Infection Caused by Highly Virulent Pseudomonas aeruginosa: Successful Treatment of a Case

Peikun Teng, Jian Peng, Xingyu Zhang, Yong‐Xia Wang, Chen Jiang, Shengyao Wang, Mingyu Wang, Xiudi Han, Xuedong LiuJournal of Inflammation Research 2025 · DOI

Abstract

This case highlights the disseminated potential of highly virulent P. aeruginosa and underscores the need for vigilance regarding secondary organizing pneumonia in such infections. Timely recognition, together with a treatment strategy combining appropriate antimicrobial and anti-inflammatory therapy, is crucial to improving patient outcomes.

Introduction

Pseudomonas aeruginosa is a notorious opportunistic pathogen, typically associated with healthcare-acquired infections in immunocompromised or ventilated patients. However, its role in severe community-acquired pneumonia (SCAP) is increasingly recognized, often presenting with high virulence and a grim prognosis. This report details a rare, life-threatening case of community-acquired P. aeruginosa that disseminated systemically, leading to endophthalmitis and skin lesions. A critical aspect of this case was the development of Secondary Organizing Pneumonia (SOP), an inflammatory "aberrant repair" response that mimics worsening infection but requires corticosteroid intervention.

Clinical Presentation and Dissemination

The patient presented with severe respiratory distress and evidence of systemic spread. Beyond the primary lung infection, the bacteria settled in distant sites, including the eyes and skin, illustrating the pathogen's high invasive potential. This systemic dissemination is a hallmark of highly virulent strains capable of breaching biological barriers.

Clinical presentation of the patient showing signs of systemic dissemination and the requirement for intensive care support.

Methods and Pathogen Analysis

To manage this complex case, clinicians utilized advanced diagnostic tools to identify the pathogen and its virulence profile:

  • Metagenomic Next-Generation Sequencing (mNGS): Rapidly identified P. aeruginosa in bronchoalveolar lavage fluid (BALF) when standard cultures were pending.
  • Whole-Genome Sequencing (WGS): Performed on ocular pus isolates, identifying the strain as Sequence Type 1207 (ST1207). WGS revealed a potent "pathogenic arsenal," including Type III secretion system (T3SS) effectors ExoS, ExoT, and ExoY, which facilitate systemic spread by injecting toxins directly into host cells.
  • Histopathology: Lung biopsies confirmed the presence of SOP, while postoperative analysis of the eyeball showed suppurative inflammation.

Management of Secondary Organizing Pneumonia (SOP)

A major diagnostic challenge was identifying when the patient's worsening condition shifted from active infection to SOP. While inflammatory markers improved with high-tier antibiotics (Meropenem, Amikacin, and Cefoperazone-sulbactam), the patient’s fever and lung imaging findings persisted. This discrepancy—clinical improvement in markers but radiographic stagnation—was the key indicator that the pathology had shifted to an inflammatory phase.

Chest CT scan (A) revealing extensive consolidation and lung lesions associated with severe P. aeruginosa infection and secondary organizing pneumonia.

Results

The introduction of systemic corticosteroids (Methylprednisolone 40mg/day) led to a rapid clinical response, with the patient's temperature normalizing within 24 hours. Follow-up CT scans at one week and three months demonstrated significant absorption of lung lesions and resolution of the organizing pneumonia. Although the systemic infection was successfully treated, the severity of the endophthalmitis necessitated the enucleation of the left eye to control the source of infection.

Conclusion

This case underscores the importance of recognizing the dual nature of severe P. aeruginosa infections: the initial bacterial onslaught and the subsequent inflammatory response (SOP). Success depends on timely pathogen identification via mNGS/WGS and the strategic use of corticosteroids once the infection is controlled but lung pathology persists. Future research into the specific virulence factors of ST1207 may provide better strategies to interrupt systemic dissemination and preserve organ function.

Summary updated

Abstract

This case highlights the disseminated potential of highly virulent <i>P. aeruginosa</i> and underscores the need for vigilance regarding secondary organizing pneumonia in such infections. Timely recognition, together with a treatment strategy combining appropriate antimicrobial and anti-inflammatory therapy, is crucial to improving patient outcomes.
BibTeX
@article{teng2025severe,
  author = {Peikun Teng and Jian Peng and Xingyu Zhang and Yong‐Xia Wang and Chen Jiang and Shengyao Wang and Mingyu Wang and Xiudi Han and Xuedong Liu},
  title = {{Severe Community-Acquired Pneumonia with Disseminated Infection Caused by Highly Virulent Pseudomonas aeruginosa: Successful Treatment of a Case}},
  journal = {Journal of Inflammation Research},
  year = {2025},
  doi = {10.2147/jir.s540213},
}
Figure